DEB-TACE Superior to TACE: Better Short-term Disease Control, Improved Survival



Despite advances in targeted therapies, TACE remains the main treatment for unresectable hepatocellular carcinoma, with DEB-TACE showing potential advantages over c-TACE amid ongoing debates about their efficacy and overall survival benefits.

Copyright © 2020 Terumo India Private limited

X
Important information regarding

By using this website, you consent to the use of cookies in accordance with our